Biomaterial delivery of morphogens to mimic the natural healing cascade in bone.
暂无分享,去创建一个
Georg N Duda | David J Mooney | Katharina Schmidt-Bleek | D. Mooney | G. Duda | K. Schmidt-Bleek | M. Mehta | Manav Mehta
[1] C. Laurencin,et al. Bone tissue engineering by gene delivery. , 2006, Advanced drug delivery reviews.
[2] D. Mooney,et al. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4) , 2005, Gene Therapy.
[3] R. Guldberg,et al. Role of hypoxia inducible factor-1α pathway in bone regeneration , 2008 .
[4] Hyun Chul Lee,et al. Remission in models of type 1 diabetes by gene therapy using a single-chain insulin analogue , 2000, Nature.
[5] W. Sebald,et al. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. , 1996, European journal of biochemistry.
[6] Britt Wildemann,et al. Long‐term effects of local growth factor (IGF‐I and TGF‐β1) treatment on fracture healing . A safety study for using growth factors , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[7] Georg N Duda,et al. Timely fracture-healing requires optimization of axial fixation stability. , 2007, The Journal of bone and joint surgery. American volume.
[8] D. E. Ashhurst,et al. The effect of exogenous transforming growth factor-beta 2 on healing fractures in the rabbit. , 1995, Bone.
[9] William A. Pierce,et al. Effect of Recombinant Human Bone Morphogenetic Protein‐2 on Fracture Healing in a Goat Tibial Fracture Model , 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[10] W. Taylor,et al. Surgical Approach Influences Periprosthetic Femoral Bone Density , 2005, Clinical orthopaedics and related research.
[11] A. Papavassiliou,et al. Segmental bone defects: from cellular and molecular pathways to the development of novel biological treatments , 2010, Journal of cellular and molecular medicine.
[12] M. Bostrom,et al. Combination of Growth Factors Inhibits Bone Ingrowth in the Bone Harvest Chamber , 2001, Clinical orthopaedics and related research.
[13] Rui L Reis,et al. Carrageenan-based hydrogels for the controlled delivery of PDGF-BB in bone tissue engineering applications. , 2009, Biomacromolecules.
[14] David J Mooney,et al. Engineering RGD nanopatterned hydrogels to control preosteoblast behavior: a combined computational and experimental approach. , 2007, Biomaterials.
[15] D. Mooney,et al. Polymeric system for dual growth factor delivery , 2001, Nature Biotechnology.
[16] V. Devescovi,et al. Growth factors in bone repair , 2008, La Chirurgia degli organi di movimento.
[17] G. Duda,et al. The early fracture hematoma and its potential role in fracture healing. , 2010, Tissue engineering. Part B, Reviews.
[18] Daniel G. Anderson,et al. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells , 2004, Nature Biotechnology.
[19] Salvatore Pernagallo,et al. Polymer microarrays for cellular high-content screening. , 2011, Methods in molecular biology.
[20] E. Schwarz,et al. Stromal cell-derived factor 1/CXCR4 signaling is critical for the recruitment of mesenchymal stem cells to the fracture site during skeletal repair in a mouse model. , 2009, Arthritis and rheumatism.
[21] N. Haas,et al. Insulin-like growth factor-1 and transforming growth factor-beta1 accelerates osteotomy healing using polylactide-coated implants as a delivery system: a biomechanical and histological study in minipigs. , 2002, Bone.
[22] David J Mooney,et al. Polymers to direct cell fate by controlling the microenvironment. , 2007, Current opinion in biotechnology.
[23] A. Nauta,et al. Immunomodulatory properties of mesenchymal stromal cells. , 2007, Blood.
[24] Masashi Suzuki,et al. Engineering of an FGF–proteoglycan fusion protein with heparin-independent, mitogenic activity , 2000, Nature Biotechnology.
[25] H. Seeherman,et al. Bone consolidation is enhanced by rhBMP‐2 in a rabbit model of distraction osteogenesis , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[26] David J Mooney,et al. Angiogenic effects of sequential release of VEGF-A165 and PDGF-BB with alginate hydrogels after myocardial infarction. , 2007, Cardiovascular research.
[27] E H Schemitsch,et al. Fracture vascularity and bone healing: a systematic review of the role of VEGF. , 2008, Injury.
[28] Monya Baker,et al. Tissue models: A living system on a chip , 2011, Nature.
[29] G. Duda,et al. Time kinetics of bone defect healing in response to BMP-2 and GDF-5 characterised by in vivo biomechanics. , 2011, European cells & materials.
[30] Yoshihiro Ito,et al. Covalently immobilized biosignal molecule materials for tissue engineering. , 2007, Soft matter.
[31] David J. Mooney,et al. Infection-Mimicking Materials to Program Dendritic Cells In Situ , 2008, Nature materials.
[32] R Langer,et al. Responsive polymeric delivery systems. , 2001, Advanced drug delivery reviews.
[33] E. A. Cavalcanti-Adam,et al. Surface immobilization of bone morphogenetic protein 2 via a self-assembled monolayer formation induces cell differentiation. , 2012, Acta biomaterialia.
[34] A. Metters,et al. Poly(ethylene glycol) hydrogels formed by conjugate addition with controllable swelling, degradation, and release of pharmaceutically active proteins. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[35] L. Schmidt‐Mende,et al. ZnO - nanostructures, defects, and devices , 2007 .
[36] G. Finerman,et al. Repair of segmental defects of the tibia with cancellous bone grafts augmented with human bone morphogenetic protein. A preliminary report. , 1988, Clinical orthopaedics and related research.
[37] M. Pirela-Cruz,et al. Management of Posttraumatic Segmental Bone Defects , 2004, The Journal of the American Academy of Orthopaedic Surgeons.
[38] H. Uludaǧ,et al. Carrier systems for bone morphogenetic proteins. , 1999, Clinical orthopaedics and related research.
[39] M. Bostrom,et al. Biosynthetic bone grafting. , 1999, Clinical orthopaedics and related research.
[40] Jason E Gestwicki,et al. Synthetic multivalent ligands as probes of signal transduction. , 2006, Angewandte Chemie.
[41] G. Duda,et al. Standard bone healing stages occur during delayed bone healing, albeit with a different temporal onset and spatial distribution of callus tissues. , 2010, Histology and histopathology.
[42] N P Haas,et al. Bone morphogenetic protein-2 coating of titanium implants increases biomechanical strength and accelerates bone remodeling in fracture treatment: a biomechanical and histological study in rats. , 2002, Bone.
[43] John Greenman,et al. A microfluidic device for tissue biopsy culture and interrogation , 2010 .
[44] K. Lyons,et al. Bone morphogenetic protein-2: biology and applications. , 1996, Clinical orthopaedics and related research.
[45] Rui L. Reis,et al. Incorporation of a sequential BMP-2/BMP-7 delivery system into chitosan-based scaffolds for bone tissue engineering. , 2009, Biomaterials.
[46] J. Vacanti,et al. Tissue engineering : Frontiers in biotechnology , 1993 .
[47] L. Hofbauer,et al. Clinical implications of the osteoprotegerin/RANKL/RANK system for bone and vascular diseases. , 2004, JAMA.
[48] V. Rosen,et al. Bone morphogenetic protein and bone morphogenetic protein gene family in bone formation and repair. , 1998, Clinical orthopaedics and related research.
[49] G. Duda,et al. Insights into Mesenchymal Stem Cell Aging: Involvement of Antioxidant Defense and Actin Cytoskeleton , 2009, Stem cells.
[50] H. Ceylan,et al. Surface-adhesive and osteogenic self-assembled peptide nanofibers for bioinspired functionalization of titanium surfaces , 2012 .
[51] C. Kirker-Head,et al. Potential applications and delivery strategies for bone morphogenetic proteins. , 2000, Advanced drug delivery reviews.
[52] V. Hasırcı,et al. Sequential BMP-2/BMP-7 delivery from polyester nanocapsules. , 2009, Journal of biomedical materials research. Part A.
[53] P J Prendergast,et al. Biophysical stimuli on cells during tissue differentiation at implant interfaces , 1997 .
[54] Zhihe Zhao,et al. Validation of β‐Actin Used as Endogenous Control for Gene Expression Analysis in Mechanobiology Studies , 2009, Stem cells.
[55] David J Mooney,et al. Controlled Growth Factor Delivery for Tissue Engineering , 2009, Advanced materials.
[56] J. Buchowski,et al. In reference to acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins , 2011, The Laryngoscope.
[57] L. Claes,et al. Magnitudes of local stress and strain along bony surfaces predict the course and type of fracture healing. , 1998, Journal of biomechanics.
[58] H. Tesluk,et al. The Effects of Insulin-like Growth Factor-1 on Critical-Size Calvarial Defects in Sprague—Dawley Rats , 1993, Annals of plastic surgery.
[59] Vivian H. Fan,et al. Tethered Epidermal Growth Factor Provides a Survival Advantage to Mesenchymal Stem Cells , 2007, Stem cells.
[60] D. Stewart,et al. Effect of cell‐based VEGF gene therapy on healing of a segmental bone defect , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[61] Antonios G Mikos,et al. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. , 2009, Tissue engineering. Part A.
[62] B. Eppley,et al. Allograft and Alloplastic Bone Substitutes: A Review of Science and Technology For the Craniomaxillofacial Surgeon , 2005, The Journal of craniofacial surgery.
[63] R. F. Morgan,et al. Insulinlike growth factor 1- and 2-augmented collagen gel repair of facial osseous defects. , 1999, Archives of otolaryngology--head & neck surgery.
[64] P. Cuevas,et al. Osteopromotion for cranioplasty: an experimental study in rats using acidic fibroblast growth factor. , 1997, Surgical neurology.
[65] D. Möbest,et al. Differentiation of osteoblasts in three-dimensional culture in processed cancellous bone matrix: quantitative analysis of gene expression based on real-time reverse transcription-polymerase chain reaction. , 2005, Tissue engineering.
[66] S. Mitragotri,et al. Ultrasound-induced cavitation: applications in drug and gene delivery , 2006, Expert opinion on drug delivery.
[67] L. Deguzman,et al. Combination of bone marrow and TGF-beta1 augment the healing of critical-sized bone defects. , 1998, Journal of pharmaceutical sciences.
[68] Abraham J. Verbout,et al. Growth factor interactions in bone regeneration. , 2010, Tissue engineering. Part B, Reviews.
[69] A. Metters,et al. Hydrogels in controlled release formulations: network design and mathematical modeling. , 2006, Advanced drug delivery reviews.
[70] Michael J Yaszemski,et al. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. , 2009, Biomaterials.
[71] David J Mooney,et al. VEGF Scaffolds Enhance Angiogenesis and Bone Regeneration in Irradiated Osseous Defects , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[72] Y. Shimabukuro,et al. Recombinant human basic fibroblast growth factor (bFGF) stimulates periodontal regeneration in class II furcation defects created in beagle dogs. , 2003, Journal of periodontal research.
[73] Jeffrey Bonadio,et al. Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration , 1999, Nature Medicine.
[74] Y. Izumi,et al. Effectable application of vascular endothelial growth factor to critical sized rat calvaria defects. , 2010, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[75] E. Verpoorte,et al. Microfluidics Enables Small-Scale Tissue-Based Drug Metabolism Studies with Scarce Human Tissue , 2011, Journal of laboratory automation.
[76] Thomas A Einhorn,et al. Fracture healing as a post‐natal developmental process: Molecular, spatial, and temporal aspects of its regulation , 2003, Journal of cellular biochemistry.
[77] Antonios G Mikos,et al. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. , 2008, Bone.
[78] S. Goldstein,et al. Stimulation of new bone formation by direct transfer of osteogenic plasmid genes. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[79] Georg N. Duda,et al. Inflammatory phase of bone healing initiates the regenerative healing cascade , 2011, Cell and Tissue Research.
[80] Robert E Guldberg,et al. Spatiotemporal Delivery Strategies for Promoting Musculoskeletal Tissue Regeneration , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[81] A. Reddi,et al. Complete regeneration of bone in the baboon by recombinant human osteogenic protein-1 (hOP-1, bone morphogenetic protein-7). , 1996, Growth factors.
[82] J. L. Santos,et al. Non-viral gene delivery to mesenchymal stem cells: methods, strategies and application in bone tissue engineering and regeneration. , 2011, Current gene therapy.
[83] J Bonadio,et al. Tissue engineering via local gene delivery: update and future prospects for enhancing the technology. , 2000, Advanced drug delivery reviews.
[84] V. Pillay,et al. Novel Modulation of Drug Delivery Using Binary Zinc-Alginate-Pectinate Polyspheres for Zero-Order Kinetics Over Several Days: Experimental Design Strategy to Elucidate the Crosslinking Mechanism , 2005, Drug development and industrial pharmacy.
[85] D. Wells,et al. Gene Therapy Progress and Prospects: Electroporation and other physical methods , 2004, Gene Therapy.
[86] Bradley K Weiner,et al. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. , 2011, The spine journal : official journal of the North American Spine Society.
[87] M. Costa,et al. The clinical use of platelet-rich plasma in the promotion of bone healing: a systematic review. , 2009, Injury.
[88] Sundeep Khosla,et al. Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease. , 2008, Endocrine reviews.
[89] P. Fratzl,et al. Designing biomimetic scaffolds for bone regeneration: why aim for a copy of mature tissue properties if nature uses a different approach? , 2010 .
[90] Georg N Duda,et al. Mechanical induction of critically delayed bone healing in sheep: radiological and biomechanical results. , 2008, Journal of biomechanics.
[91] S. Goldstein,et al. In vivo nonviral delivery factors to enhance bone repair. , 2000, Clinical orthopaedics and related research.
[92] A. Burstein,et al. The healing of segmental bone defects induced by demineralized bone matrix. A radiographic and biomechanical study. , 1984, The Journal of bone and joint surgery. American volume.
[93] Thomas A Einhorn,et al. Differential Temporal Expression of Members of the Transforming Growth Factor β Superfamily During Murine Fracture Healing , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[94] F. Nociti,et al. Platelet-derived growth factor/insulin-like growth factor-1 combination and bone regeneration around implants placed into extraction sockets: a histometric study in dogs. , 2000, Implant dentistry.
[95] J. Poser,et al. Novel formulation of fibroblast growth factor‐2 in a hyaluronan gel accelerates fracture healing in nonhuman primates , 1999, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[96] T. Clemens,et al. Mesenchymal stem cells expressing osteogenic and angiogenic factors synergistically enhance bone formation in a mouse model of segmental bone defect. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.
[97] David J Mooney,et al. Quantitative assessment of scaffold and growth factor‐mediated repair of critically sized bone defects , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[98] J. Hollinger,et al. A Bone Regeneration Study: Transforming Growth Factor‐β1 and Its Delivery , 1996 .
[99] Michael J Yaszemski,et al. Non-invasive monitoring of BMP-2 retention and bone formation in composites for bone tissue engineering using SPECT/CT and scintillation probes. , 2009, Journal of controlled release : official journal of the Controlled Release Society.
[100] Kenneth M. Yamada,et al. Taking Cell-Matrix Adhesions to the Third Dimension , 2001, Science.
[101] David J. Mooney,et al. Non-viral gene delivery regulated by stiffness of cell adhesion substrates , 2005, Nature materials.
[102] D. Muscolo,et al. Massive allograft use in orthopedic oncology. , 2006, The Orthopedic clinics of North America.
[103] P. Aspenberg,et al. CDMP‐2 induces bone or tendon‐like tissue depending on mechanical stimulation , 2002, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[104] Guangzhi Wang,et al. Optimal delivery systems for bone morphogenetic proteins in orthopedic applications should model initial tissue repair structures by using a heparin-incorporated fibrin-fibronectin matrix. , 2008, Medical hypotheses.
[105] Byung-Soo Kim,et al. Enhancement of ectopic bone formation by bone morphogenetic protein-2 released from a heparin-conjugated poly(L-lactic-co-glycolic acid) scaffold. , 2007, Biomaterials.
[106] David J Mooney,et al. An alginate-based hybrid system for growth factor delivery in the functional repair of large bone defects. , 2011, Biomaterials.
[107] W. Sufan,et al. Alginate hydrogel linked with synthetic oligopeptide derived from BMP-2 allows ectopic osteoinduction in vivo. , 2000, Journal of biomedical materials research.
[108] K. Ohya,et al. Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats. , 2006, Tissue engineering.
[109] D J Mooney,et al. Alginate hydrogels as synthetic extracellular matrix materials. , 1999, Biomaterials.
[110] S. Parikh. Bone graft substitutes: past, present, future. , 2002, Journal of postgraduate medicine.
[111] Bong Geun Chung,et al. High-throughput screening of cell responses to biomaterials. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[112] K W Anderson,et al. Cell-interactive Alginate Hydrogels for Bone Tissue Engineering , 2001, Journal of dental research.
[113] M. Becker,et al. Synergistic enhancement of human bone marrow stromal cell proliferation and osteogenic differentiation on BMP-2-derived and RGD peptide concentration gradients. , 2011, Acta biomaterialia.
[114] Thomas Mittlmeier,et al. Bone morphogenetic protein-2 application by a poly(D,L-lactide)-coated interbody cage: in vivo results of a new carrier for growth factors. , 2002, Journal of neurosurgery.
[115] Robert Langer,et al. Biomaterial microarrays: rapid, microscale screening of polymer-cell interaction. , 2005, Biomaterials.
[116] N. Peppas,et al. Factors influencing drug and protein transport and release from ionic hydrogels , 1995 .
[117] Hollinger,et al. Sustained release emphasizing recombinant human bone morphogenetic protein-2. , 1998, Advanced drug delivery reviews.
[118] J. Miyazaki,et al. Simple strategy for bone regeneration with a BMP-2/7 gene expression cassette vector. , 2009, Biochemical and biophysical research communications.
[119] David J. Mooney,et al. Growth Factors, Matrices, and Forces Combine and Control Stem Cells , 2009, Science.
[120] David J. Mooney,et al. DNA delivery from polymer matrices for tissue engineering , 1999, Nature Biotechnology.
[121] Fa-Ming Chen,et al. In vitro cellular responses to scaffolds containing two microencapulated growth factors. , 2009, Biomaterials.
[122] H. Redmond,et al. Is human fracture hematoma inherently angiogenic , 2000 .
[123] C Perka,et al. Segmental bone repair by tissue-engineered periosteal cell transplants with bioresorbable fleece and fibrin scaffolds in rabbits. , 2000, Biomaterials.
[124] M J Yaszemski,et al. Polymer concepts in tissue engineering. , 1998, Journal of biomedical materials research.
[125] Christina Eckhardt,et al. Vascular Endothelial Growth Factor Gene‐Activated Matrix (VEGF165‐GAM) Enhances Osteogenesis and Angiogenesis in Large Segmental Bone Defects , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[126] B. Ratner,et al. The engineering of biomaterials exhibiting recognition and specificity , 1996, Journal of molecular recognition : JMR.
[127] R. Weissleder,et al. Cell-specific targeting of nanoparticles by multivalent attachment of small molecules , 2005, Nature Biotechnology.
[128] Maryam Tabrizian,et al. Delivery of recombinant bone morphogenetic proteins for bone regeneration and repair. Part A: Current challenges in BMP delivery , 2009, Biotechnology Letters.
[129] David W. Rowe,et al. Live-animal tracking of individual haematopoietic stem/progenitor cells in their niche , 2009, Nature.
[130] K. Yaremchuk,et al. Acute airway obstruction in cervical spinal procedures with bone morphogenetic proteins , 2010, The Laryngoscope.
[131] Paula T Hammond,et al. Tunable dual growth factor delivery from polyelectrolyte multilayer films. , 2011, Biomaterials.
[132] C. Yellowley,et al. Hypoxic regulation of mesenchymal stem cell migration: the role of RhoA and HIF‐1α , 2011, Cell biology international.
[133] R E Guldberg,et al. Analyzing bone, blood vessels, and biomaterials with microcomputed tomography. , 2003, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.
[134] David J Mooney,et al. Cell delivery mechanisms for tissue repair. , 2008, Cell stem cell.
[135] Takaaki Tanaka,et al. Repair of segmental bone defects in rabbit tibiae using a complex of beta-tricalcium phosphate, type I collagen, and fibroblast growth factor-2. , 2006, Biomaterials.
[136] L. Claes,et al. Bone formation in a long bone defect model using a platelet-rich plasma-loaded collagen scaffold. , 2006, Biomaterials.
[137] Francesca Ungaro,et al. Controlled drug delivery in tissue engineering. , 2008, Advanced drug delivery reviews.
[138] David J Mooney,et al. Mimicking nature by codelivery of stimulant and inhibitor to create temporally stable and spatially restricted angiogenic zones , 2010, Proceedings of the National Academy of Sciences.
[139] Georg N Duda,et al. Endochondral ossification in vitro is influenced by mechanical bending. , 2007, Bone.
[140] M. Liebergall,et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. , 2006, Tissue engineering.
[141] R Cancedda,et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. , 2001, The New England journal of medicine.
[142] J. Pohl,et al. A preliminary report on the effect of dimeric rhGDF-5 and its monomeric form rhGDF-5C465A on bone healing of rat cranial defects. , 2009, Journal of cranio-maxillo-facial surgery : official publication of the European Association for Cranio-Maxillo-Facial Surgery.
[143] Hanna Parnas,et al. Mathematical modeling and optimization of drug delivery from intratumorally injected microspheres. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.
[144] S. Kadiyala,et al. Culture-expanded, bone marrow-derived mesenchymal stem cells can regenerate a critical-sized segmental bone defect , 1997 .
[145] Jason A Burdick,et al. Delivery of osteoinductive growth factors from degradable PEG hydrogels influences osteoblast differentiation and mineralization. , 2002, Journal of controlled release : official journal of the Controlled Release Society.
[146] R. Oreffo,et al. Gene delivery in bone tissue engineering: progress and prospects using viral and nonviral strategies. , 2004, Tissue engineering.
[147] David J Mooney,et al. Temporally regulated delivery of VEGF in vitro and in vivo. , 2006, Journal of biomedical materials research. Part A.
[148] Johnny Huard,et al. Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4. , 2002, The Journal of clinical investigation.
[149] J. Lee,et al. Osteoprogenitor cells within skeletal muscle , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[150] A. Caplan. New era of cell-based orthopedic therapies. , 2009, Tissue engineering. Part B, Reviews.
[151] D. Davy,et al. The effect of osteogenin (a bone morphogenetic protein) on the formation of bone in orthotopic segmental defects in rats. , 1994, The Journal of bone and joint surgery. American volume.
[152] David J Mooney,et al. Integrated approach to designing growth factor delivery systems , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[153] B P F Lelieveldt,et al. Optical advances in skeletal imaging applied to bone metastases. , 2011, Bone.
[154] Dennis R. Carter,et al. Mechanobiology of Skeletal Regeneration , 1998, Clinical orthopaedics and related research.
[155] Shigeru Kobayashi,et al. Bone formation on apatite-coated titanium with incorporated BMP-2/heparin in vivo. , 2009, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.
[156] Jörg A Auer,et al. Localized insulin-like growth factor I delivery to enhance new bone formation. , 2003, Bone.
[157] D. Puleo,et al. In vitro effects of combined and sequential delivery of two bone growth factors. , 2004, Biomaterials.
[158] H. Frost,et al. A determinant of bone architecture. The minimum effective strain. , 1983, Clinical orthopaedics and related research.
[159] R Langer,et al. Novel approach to fabricate porous sponges of poly(D,L-lactic-co-glycolic acid) without the use of organic solvents. , 1996, Biomaterials.
[160] G N Duda,et al. Mechanobiology of bone healing and regeneration: in vivo models , 2010, Proceedings of the Institution of Mechanical Engineers. Part H, Journal of engineering in medicine.
[161] T. Steffen,et al. Porous tricalcium phosphate and transforming growth factor used for anterior spine surgery , 2001, European Spine Journal.
[162] E. Rodríguez‐Merchán,et al. Nonunion: general principles and experimental data. , 2004, Clinical orthopaedics and related research.
[163] T A Einhorn,et al. The cell and molecular biology of fracture healing. , 1998, Clinical orthopaedics and related research.
[164] Vasif Hasirci,et al. Sequential growth factor delivery from complexed microspheres for bone tissue engineering. , 2008, Biomaterials.
[165] Jay R Lieberman,et al. The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.
[166] D. Mooney,et al. Targeted delivery of nanoparticles to ischemic muscle for imaging and therapeutic angiogenesis. , 2011, Nano letters.
[167] Georg N Duda,et al. Insight into the molecular pathophysiology of delayed bone healing in a sheep model. , 2010, Tissue engineering. Part A.
[168] D. Graves,et al. Impaired Fracture Healing in the Absence of TNF‐α Signaling: The Role of TNF‐α in Endochondral Cartilage Resorption , 2003 .
[169] A. Aono,et al. Potent ectopic bone-inducing activity of bone morphogenetic protein-4/7 heterodimer. , 1995, Biochemical and biophysical research communications.
[170] D. Mooney,et al. Alginate: properties and biomedical applications. , 2012, Progress in polymer science.
[171] N. Gallay,et al. The In Vitro Migration Capacity of Human Bone Marrow Mesenchymal Stem Cells: Comparison of Chemokine and Growth Factor Chemotactic Activities , 2007, Stem cells.
[172] D. Mooney,et al. Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[173] David J Mooney,et al. New materials for tissue engineering: towards greater control over the biological response. , 2008, Trends in biotechnology.
[174] C. Ackert-Bicknell,et al. Marrow fat and the bone microenvironment: developmental, functional, and pathological implications. , 2009, Critical reviews in eukaryotic gene expression.
[175] G. Duda,et al. Locally applied osteogenic predifferentiated progenitor cells are more effective than undifferentiated mesenchymal stem cells in the treatment of delayed bone healing. , 2009, Tissue engineering. Part A.
[176] H Willenegger,et al. [Primary and secondary healing of bone fractures]. , 1971, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[177] Eben Alsberg,et al. Dual growth factor delivery and controlled scaffold degradation enhance in vivo bone formation by transplanted bone marrow stromal cells. , 2004, Bone.
[178] G. Schmidmaier,et al. Sequential release kinetics of two (gentamicin and BMP-2) or three (gentamicin, IGF-I and BMP-2) substances from a one-component polymeric coating on implants. , 2011, Journal of controlled release : official journal of the Controlled Release Society.
[179] C. R. Howlett,et al. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. , 1994, Bone.
[180] S. Bauer,et al. Covalent functionalization of TiO2 nanotube arrays with EGF and BMP-2 for modified behavior towards mesenchymal stem cells. , 2011, Integrative biology : quantitative biosciences from nano to macro.
[181] A. Khademhosseini,et al. Hydrogels in Regenerative Medicine , 2009, Advanced materials.
[182] J. Hubbell,et al. Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering , 2005, Nature Biotechnology.
[183] Georg N Duda,et al. Instability prolongs the chondral phase during bone healing in sheep. , 2006, Bone.
[184] L. Tagliabue,et al. Application of rhBMP-7 and platelet-rich plasma in the treatment of long bone non-unions: a prospective randomised clinical study on 120 patients. , 2008, Injury.
[185] D. Heymann,et al. Mechanisms of bone repair and regeneration. , 2009, Trends in molecular medicine.
[186] H. Redmond,et al. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[187] Jae-Hyung Jang,et al. Gene delivery from polymer scaffolds for tissue engineering , 2004, Expert review of medical devices.
[188] D. Hutmacher,et al. Spatiotemporal delivery of bone morphogenetic protein enhances functional repair of segmental bone defects. , 2011, Bone.
[189] Yoshihiro Ito,et al. Peptide immobilized on gold particles enhances cell growth , 2008, Cytotechnology.
[190] David J. Mooney,et al. Polymeric Growth Factor Delivery Strategies for Tissue Engineering , 2003, Pharmaceutical Research.
[191] H. Vandenburgh,et al. The role of multifunctional delivery scaffold in the ability of cultured myoblasts to promote muscle regeneration. , 2011, Biomaterials.
[192] M. Somerman,et al. Growth factors regulate expression of osteoblast-associated genes. , 1999, Journal of periodontology.
[193] Y. Jin,et al. Induction of new bone by ceramic bovine bone with recombinant human bone morphogenetic protein 2 and transforming growth factor beta. , 1998, International journal of oral and maxillofacial surgery.
[194] M. Vallet‐Regí,et al. Immobilization and bioactivity evaluation of FGF-1 and FGF-2 on powdered silicon-doped hydroxyapatite and their scaffolds for bone tissue engineering , 2011, Journal of materials science. Materials in medicine.
[195] Antonios G Mikos,et al. Harnessing and modulating inflammation in strategies for bone regeneration. , 2011, Tissue engineering. Part B, Reviews.
[196] Chao Wan,et al. The hypoxia-inducible factor alpha pathway couples angiogenesis to osteogenesis during skeletal development. , 2007, The Journal of clinical investigation.
[197] David J Mooney,et al. Upregulation of bone cell differentiation through immobilization within a synthetic extracellular matrix. , 2007, Biomaterials.
[198] J. Ong,et al. Experimental studies on bone induction using low-molecular-weight poly (DL-lactide-co-glycolide) as a carrier for recombinant human bone morphogenetic protein-2. , 2002, Journal of biomedical materials research.
[199] Nastaran Zahir,et al. Death in the third dimension: apoptosis regulation and tissue architecture. , 2004, Current opinion in genetics & development.
[200] M. Swiontkowski,et al. Bone-graft substitutes , 1999, The Lancet.
[201] Satoru Kidoaki,et al. Time-programmed dual release formulation by multilayered drug-loaded nanofiber meshes. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[202] S. Goodman,et al. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. , 2010, Cytokine.
[203] Stefaan C. De Smedt,et al. “Programmed Polymeric Devices” for Pulsed Drug Delivery , 2004, Pharmaceutical Research.
[204] Renjing Liu,et al. Myogenic progenitors contribute to open but not closed fracture repair , 2011, BMC musculoskeletal disorders.
[205] David J. Mooney,et al. Controlled growth factor release from synthetic extracellular matrices , 2000, Nature.
[206] L. Claes,et al. Early dynamization by reduced fixation stiffness does not improve fracture healing in a rat femoral osteotomy model , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[207] Reine Bareille,et al. Influences of vascularization and osteogenic cells on heterotopic bone formation within a madreporic ceramic in rats. , 2003, Plastic and reconstructive surgery.
[208] R. Weissleder,et al. Imaging in the era of molecular oncology , 2008, Nature.
[209] T. Gaber,et al. Hypoxia inducible factor (HIF) in rheumatology: low O2! See what HIF can do! , 2005, Annals of the rheumatic diseases.
[210] R. Schugar,et al. Small molecules in stem cell self-renewal and differentiation , 2008, Gene Therapy.
[211] M. Maeda,et al. Continuous Administration of Basic Fibroblast Growth Factor (FGF-2) Accelerates Bone Induction on Rat Calvaria— An Application of a New Drug Delivery System , 1998, Journal of dental research.
[212] J. Welsh,et al. Ligand-induced transformation by a noninternalizing epidermal growth factor receptor. , 1990, Science.
[213] Ann Sandison,et al. Comparison of the Vascularity of Fasciocutaneous Tissue and Muscle for Coverage of Open Tibial Fractures , 2009, Plastic and reconstructive surgery.
[214] Deenu Kanjickal,et al. Modeling of drug release from polymeric delivery systems--a review. , 2004, Critical reviews in therapeutic drug carrier systems.
[215] Britt Wildemann,et al. Synergistic effect of IGF-I and TGF-ß1 on fracture healing in ratsSingle versus combined application of IGF-I and TGF-ß1 , 2003, Acta orthopaedica Scandinavica.
[216] Y. Ikada,et al. Promoted bone healing at a rabbit skull gap between autologous bone fragment and the surrounding intact bone with biodegradable microspheres containing transforming growth factor-beta1. , 2000, Tissue engineering.
[217] L Claes,et al. [Mechanical modification of callus healing]. , 2000, Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen.
[218] Ralph Müller,et al. Repair of bone defects using synthetic mimetics of collagenous extracellular matrices , 2003, Nature Biotechnology.
[219] B L Currier,et al. Biological activity of rhBMP-2 released from PLGA microspheres. , 2000, Journal of biomechanical engineering.
[220] N. Demertzis,et al. Reconstruction of tibia defects by ipsilateral vascularized fibula transposition , 2008, Archives of Orthopaedic and Trauma Surgery.
[221] Y. M. Lee,et al. The bone regenerative effect of platelet-derived growth factor-BB delivered with a chitosan/tricalcium phosphate sponge carrier. , 2000, Journal of periodontology.
[222] Thomas A Einhorn,et al. The biology of fracture healing. , 2011, Injury.
[223] N. Epstein,et al. Pros, cons, and costs of INFUSE in spinal surgery , 2011, Surgical neurology international.
[224] L. Xing,et al. Functions of RANKL/RANK/OPG in bone modeling and remodeling. , 2008, Archives of biochemistry and biophysics.
[225] Vladimir Volloch,et al. Bone morphogenetic protein-2 decorated silk fibroin films induce osteogenic differentiation of human bone marrow stromal cells. , 2004, Journal of biomedical materials research. Part A.
[226] Georg N Duda,et al. Differential regulation of blood vessel formation between standard and delayed bone healing , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[227] Stuart B Goodman,et al. The sequential expression profiles of growth factors from osteoprogenitors [correction of osteroprogenitors] to osteoblasts in vitro. , 2007, Tissue engineering.
[228] Lutz Claes,et al. Mechanical characterization of external fixator stiffness for a rat femoral fracture model , 2009, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.
[229] C. Bosch,et al. Recombinant Transforming Growth Factor‐β1 Induces Endochondral Bone in the Baboon and Synergizes with Recombinant Osteogenic Protein‐1 (Bone Morphogenetic Protein‐7) to Initiate Rapid Bone Formation , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[230] R. Guldberg,et al. A Perspective: Engineering Periosteum for Structural Bone Graft Healing , 2008, Clinical orthopaedics and related research.
[231] T. Einhorn,et al. Impaired Intramembranous Bone Formation during Bone Repair in the Absence of Tumor Necrosis Factor-Alpha Signaling , 2001, Cells Tissues Organs.
[232] D J Mooney,et al. Regulating Bone Formation via Controlled Scaffold Degradation , 2003, Journal of dental research.
[233] Y. Ito,et al. Protein-free cell culture on an artificial substrate with covalently immobilized insulin. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[234] Charles A Gersbach,et al. Virus-based gene therapy strategies for bone regeneration. , 2007, Biomaterials.
[235] G. Pelled,et al. Ultrasound-based nonviral gene delivery induces bone formation in vivo , 2008, Gene Therapy.
[236] M. Schütz,et al. Cyclic strain disrupts endothelial network formation on Matrigel. , 2009, Microvascular research.
[237] K. Kozloff,et al. Near‐infrared fluorescent probe traces bisphosphonate delivery and retention in vivo , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[238] Christopher B. Rives,et al. Plasmid delivery in vivo from porous tissue-engineering scaffolds: transgene expression and cellular transfection. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.
[239] G. Duda,et al. Fracture healing is accelerated in the absence of the adaptive immune system , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[240] E. Brogi,et al. Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. , 1994, The Journal of clinical investigation.
[241] G. Duda,et al. Mechanical stimulation of the pro-angiogenic capacity of human fracture haematoma: involvement of VEGF mechano-regulation. , 2010, Bone.
[242] G. Duda,et al. Characterization of a rat osteotomy model with impaired healing , 2008, BMC musculoskeletal disorders.
[243] G. Duda,et al. A 5-mm femoral defect in female but not in male rats leads to a reproducible atrophic non-union , 2010, Archives of Orthopaedic and Trauma Surgery.
[244] Richard O C Oreffo,et al. Bone tissue engineering: hope vs hype. , 2002, Biochemical and biophysical research communications.
[245] J. Wozney,et al. Implantation of recombinant human bone morphogenetic proteins with biomaterial carriers: A correlation between protein pharmacokinetics and osteoinduction in the rat ectopic model. , 2000, Journal of biomedical materials research.
[246] D. Marsh,et al. Concepts of fracture union, delayed union, and nonunion. , 1998, Clinical orthopaedics and related research.
[247] A. Mikos,et al. TGF-&bgr;1 Release from Biodegradable Polymer Microparticles: Its Effects on Marrow Stromal Osteoblast Function , 2001, The Journal of bone and joint surgery. American volume.
[248] S. Glassman,et al. Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion , 2006, Spine.
[249] Y. Izumi,et al. Recombinant human growth/differentiation factor-5 (rhGDF-5) induced bone formation in murine calvariae. , 2006, Journal of periodontal research.
[250] G. Pelled,et al. Applications of gene therapy and adult stem cells in bone bioengineering. , 2006, Regenerative medicine.
[251] N. Peppas,et al. Present and future applications of biomaterials in controlled drug delivery systems. , 1981, Biomaterials.
[252] P. Kostenuik,et al. Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. , 2001, Current pharmaceutical design.
[253] Yoshihisa Suzuki,et al. Accelerated bone repair with the use of a synthetic BMP-2-derived peptide and bone-marrow stromal cells. , 2005, Journal of biomedical materials research. Part A.